Intestinal oversecretion of apo-B48 lipoproteins and lipids contributes to dyslipidemia in a rodent model of metabolic syndrome and PCOS, correlating with insulin and testosterone levels.
No takes yet. Share an insight, caveat, or question.
May implicate intestinal apo-B48 oversecretion in PCOS dyslipidemia; leaves open translation to human patients.
A 2014 study studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: